Expert Review of Respiratory Medicine

Article	Citations
Mortality in COVID-19 patients with acute respiratory distress syndrome and corticosteroids use: a systematic review and meta-analysis	180
Multiple organ dysfunction in SARS-CoV-2: MODS-CoV-2	175
False-positive and false-negative COVID-19 cases: respiratory prevention and management strategies, vaccination, and further perspectives	80
Pulmonary fibrosis secondary to COVID-19: a narrative review	61
Extrapulmonary tuberculosis	55
Artificial intelligence and machine learning in respiratory medicine	52
Endothelial to mesenchymal transition (EndMT) and vascular remodeling in pulmonary hypertension and idiopathic pulmonary fibrosis	44
Reported quality of life in countries with cases of COVID19: a systematic review	41
Rehabilitation of patients with COVID-19	39
Diagnostic approaches in COVID-19: clinical updates	39
Mesenchymal stromal cells for acute respiratory distress syndrome (ARDS), sepsis, and COVID-19 infection: optimizing the therapeutic potential	39
Pre-existing COPD is associated with an increased risk of mortality and severity in COVID-19: a rapid systematic review and meta-analysis	35
The long-lasting effects of the acute respiratory distress syndrome	32
The COVID-19 pandemic: a target for surfactant therapy?	31
Acute respiratory distress syndrome (ARDS) caused by the novel coronavirus disease (COVID-19): a practical comprehensive literature review	30
Evaluating triple ICS/LABA/LAMA therapies for COPD patients: a network meta-analysis of ETHOS, KRONOS, IMPACT, and TRILOGY studies	29
Role of fever and ambient temperature in COVID-19	29
Dupilumab-induced hypereosinophilia: review of the literature and algorithm proposal for clinical management	29
Endobronchial valve therapy for severe emphysema: an overview of valve-related complications and its management	28
Clinical evaluation of Shufeng Jiedu Capsules combined with umifenovir (Arbidol) in the treatment of common-type COVID-19: a retrospective study	28
An overview of the available treatments for chronic cavitary pulmonary aspergillosis	27
COPD patients in a COVID-19 society: depression and anxiety	25
Opioids/cannabinoids as a potential therapeutic approach in COVID-19 patients	25
Ten challenging questions about SARS-CoV-2 and COVID-19	24
Reduced risk of COVID-19 hospitalization in asthmatic and COPD patients: a benefit of inhaled corticosteroids?	23

Nontuberculous mycobacterial lung disease caused by Mycobacterium avium complex - disease burden, unmet needs, and advances in treatment developments	22
Value of serum soluble interleukin-2 receptor as a diagnostic and predictive biomarker in sarcoidosis	21
Development of elexacaftor – tezacaftor – ivacaftor: Highly effective CFTR modulation for the majority of people with Cystic Fibrosis	21
Smoking-associated interstitial lung disease: update and review	21
Endo-phenotyping of COPD patients	20
Cardiorespiratory and skeletal muscle damage due to COVID-19: making the urgent case for rehabilitation	18
Ibuprofen and COVID-19 disease: separating the myths from facts	18
COVID-19 Smart Diagnosis in the Emergency Department: all-in in Practice	18
Influences of environmental exposures on individuals living with cystic fibrosis	18
Epithelial dysfunction, respiratory infections and asthma: the importance of immunomodulation. A focus on OM-85	18
Strategies for the prevention, diagnosis and treatment of COPD in low- and middle- income countries: the importance of primary care	17
The impact of maternal asthma during pregnancy on fetal growth and development: a review	17
Pseudomonas aeruginosa in bronchiectasis: infection, inflammation, and therapies	17
Multidrug-resistant tuberculosis in children and adolescents: current strategies for prevention and treatment	17
Allergen immunotherapy: what is the added value of real-world evidence from retrospective claims database studies?	17
The right interface for the right patient in noninvasive ventilation: a systematic review	17
COVID-19 patients require multi-disciplinary rehabilitation approaches to address persisting symptom profiles and restore pre-COVID quality of life	17
Chronic obstructive pulmonary disease in HIV	17
Bronchoalveolar lavage: role in the evaluation of pulmonary interstitial disease	16
The role of essential organ-based comorbidities in the prognosis of COVID-19 infection patients	16
Outcomes of acute respiratory distress syndrome in COVID-19 patients compared to the general population: a systematic review and meta-analysis	16
Social determinants of tuberculosis: context, framework, and the way forward to ending TB in India	16
Extra-pulmonary manifestations of COPD and the role of pulmonary rehabilitation: a symptom-centered approach	16
Does methylprednisolone reduce the mortality risk in hospitalized COVID-19 patients? A meta-analysis of randomized control trials	15
Covid-19: a comprehensive review of a formidable foe and the road ahead	15
Impact of long-term exposure wildfire smog on respiratory health outcomes	15
What can be done to impact respiratory inhaler misuse: exploring the problem, reasons, and solutions	15
Lung function parameters among Australian Aboriginal ‘apparently healthy’ adults: an Australian Caucasian and Global Lung Function Initiative (GLI-2012) various ethnic norms comparative study	15
Influences of environmental exposures on preterm lung disease	15
Understanding the relationships between environmental factors and exacerbations of COPD	15
Critical analysis of spirometric patterns in correlation to chest computed tomography among adult Indigenous Australians with chronic airway diseases	15
Innate and adaptive immune responses in respiratory virus infection: implications for the clinic	15
An update on the role of chronic rhinosinusitis with nasal polyps as a co-morbidity in severe asthma	14
Advances in the diagnosis of fungal pneumonias	14
Role of the mucins in pathogenesis of COPD: implications for therapy	14
Machine learning in asthma research: moving toward a more integrated approach	14
Impact of the COVID-19 pandemic on the management of chronic noninfectious respiratory diseases	13
Sleep apnea is associated with the increase of certain genera of Ruminococcaceae and Lachnospiraceae in the gut microbiome of hypertensive patients	13
Depression and anxiety in patients with interstitial lung disease	13
Tuberculosis related stigma in India: roadblocks and the way forward	13
Current state of the art and future perspectives with immunotherapy in the management of small cell lung cancer	13
Could E-cigarette vaping contribute to heart disease?	13
COPD in Biomass exposed nonsmokers: a different phenotype	12
Recent developments in the pathobiology of lung myofibroblasts	12
Mediastinal lymphadenopathy: a practical approach	12
Medical thoracoscopy in the diagnosis of pleural disease: a guide for the clinician	12
Functional tests associated with sarcopenia in moderate chronic obstructive pulmonary disease	12
The rising of allergic respiratory diseases in a changing world: from climate change to migration	12
An update on current treatment strategies for managing bronchiolitis obliterans syndrome after lung transplantation	12
Clinical characteristics and outcomes of hospitalized COVID-19 patients with COPD	12

Cognitive impairment in COPD: an often overlooked co-morbidity	11
Tuberculosis in children with severe acute malnutrition	11
Pediatric bronchoscopy: recent advances and clinical challenges	11
COVID-19 clinical phenotypes and short-term outcomes: differences between the first and the second wave of pandemic in Italy	11
Benralizumab: an updated treatment of eosinophilic asthma	11
An effective drug against COVID-19: reality or dream?	11
DNA methylation in pulmonary fibrosis and lung cancer	11
Managing thrombosis and cardiovascular complications of COVID-19: answering the questions in COVID-19-associated coagulopathy	11
Clinical characteristics of COVID-19 patients with HIV coinfection in Wuhan, China	11
HIV TB coinfection - perspectives from India	11
Sex steroid hormones and asthma in women: state-of-the-art and future research perspectives	11
Pulmonary manifestations of gastroesophageal reflux disease	11
Convalescent plasma therapy in COVID-19: Unravelling the data using the principles of antibody therapy	11
SARS-CoV-2 variants of concern and vaccine escape, from Alpha to Omicron and beyond	10
Granulomatous lung disease: clinical aspects	10
Pulmonary fibrosis associated with rheumatoid arthritis: from pathophysiology to treatment strategies	10
Association between sarcoidosis and diabetes mellitus: a systematic review and meta-analysis	10
Prediction of stroke-associated pneumonia by the A2DS2, AIS-APS, and ISAN scores: a systematic review and meta-analysis	10
Comorbidities and mortality risk factors for patients with bronchiectasis	10
Role of acute exacerbations in skeletal muscle impairment in COPD	10
Association of TGF-β3 and ANXA11 with pulmonary sarcoidosis in Greek population	10
Catastrophic antiphospholipid antibody syndrome and multiple organ dysfunctions in critically ill patients with COVID-19	10
The Glasgow Prognostic Score and fibrinogen to albumin ratio as prognostic factors in hospitalized patients with COVID-19	10
Myofunctional therapy for OSA: a meta-analysis	10
Ten things you need to know about intensive care unit management of mechanically ventilated patients with COVID-19	10
A comprehensive clinical guide forPneumocystis jiroveciipneumonia: a missing therapeutic target in HIV-uninfected patients	9
Corticosteroids treatment in severe patients with COVID-19: a propensity score matching study	9
COVID-19 ‘asymptomatic’ patients: an old wives’ tale	9
Determining the appropriate treatment for different EGFR mutations in non-small cell lung cancer patients	9
The diagnostic value of CEA for lung cancer-related malignant pleural effusion in China: a meta-analysis	9
Bilevel and continuous positive airway pressure and factors linked to all-cause mortality in COVID-19 patients in an intermediate respiratory intensive care unit in Italy	9
Clinical features associated with a doctor-diagnosis of bronchiectasis in the Severe Asthma Network in Italy (SANI) registry	9
Which one is superior in predicting 30 and 90 days mortality after COPD exacerbation: DECAF, CURB-65, PSI, BAP-65, PLR, NLR	8
Management of COVID-19 from the pulmonologist’s perspective: a narrative review	8
Obstructive sleep apnea: personalizing CPAP alternative therapies to individual physiology	8
The effect of teach-back training intervention of breathing exercise on the level of dyspnea, six-minutes walking test and FEV1/FVC ratio in patients with chronic obstructive pulmonary disease; a rand	8
Immune checkpoint inhibitors: a new landscape for extensive stage small cell lung cancer treatment	8
Transbronchial Lung Cryobiopsy in children	8
Step-up and step-down approaches in the treatment of asthma	8
Recommendations for COPD management in Central and Eastern Europe	8
Effectiveness, safety and efficacy of INTELLiVENT–adaptive support ventilation, a closed–loop ventilation mode for use in ICU patients – a systematic review	8
COVID-19 first anniversary review of cases, hospitalization, and mortality in the UK	8
Health impact of e-cigarettes and heated tobacco products in chronic obstructive pulmonary disease: current and emerging evidence	7
Real-life survey on severe asthma patients during COVID-19 lockdown in Italy	7
Human rhinovirus infection and COPD: role in exacerbations and potential for therapeutic targets	7
Overprescription of short-acting β2-agonists is associated with poor asthma symptom control: results from five Middle Eastern countries included in the SABINA International (III) study	7
A multimodal approach to detect and monitor early lung disease in cystic fibrosis	7
Understanding hydrogen sulfide signaling in neonatal airway disease	7
Chest radiographs may assist in predicting the outcome in the early phase of Covid-19. UK district general hospital experience of Covid-19 first wave	7
Effects of anemia on the survival of patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis	7
Association of mild cognitive impairment and characteristic of COPD and overall health status in a cohort study	7
Using forced vital capacity (FVC) in the clinic to monitor patients with idiopathic pulmonary fibrosis (IPF): pros and cons	7
Diagnostic management of acute pulmonary embolism in special populations	7
Novel therapeutic approaches targeting endotypes of severe airway disease	7
Influenza and pneumonia-attributed deaths among cancer patients in the United States; a population-based study	7
Acute oxygen therapy: a cross-sectional study of prescribing practices at an English hospital immediately before COVID-19 pandemic	6
Predictive biomarkers for response to omalizumab in patients with severe allergic asthma: a meta-analysis	6
Exposure to cleaning products and childhood asthma: more than just a link?	6
The use of tobramycin for Pseudomonas aeruginosa: a review	6
Advances in understanding of mechanisms related to increased cardiovascular risk in COPD	6
High-flow versus conventional nasal cannula oxygen supplementation therapy and risk of hypoxia in gastrointestinal endoscopies: a systematic review and meta-analysis	6
Reorganizing the respiratory high dependency unit for pandemics	6
Personal protective equipment in the siege of respiratory viral pandemics: strides made and next steps	6
Ivacaftor for the treatment of cystic fibrosis in children under six years of age	6
Predictors of outcome of pleurodesis in patients with malignant pleural effusion: a systematic review and meta-analysis	6
Managing cystic fibrosis in children aged 6-11yrs: a critical review of elexacaftor/tezacaftor/ivacaftor combination therapy	6
The ‘clinically significant’ bronchodilator responsiveness (BDR) in children: a comparative study between six definitions of scholarly societies and a mini-review	6
IL-26 in asthma and COPD	6
Biomarkers and their potential functions in idiopathic pulmonary fibrosis	6
Management of acute upper respiratory tract infection: the role of early intervention	6
Redox signaling and antioxidant therapies in acute respiratory distress syndrome: a systematic review and meta-analysis	6
Post COVID-19 bronchiectasis: a potential epidemic within a pandemic	6
Immunopathogenesis and therapeutic potential of macrophage influx in diffuse parenchymal lung diseases	6
Asthma and COPD medicines prescription-claims: A time-series analysis of England’s national prescriptions during the COVID-19 pandemic (Jan 2019 to Oct 2020)	6
The Glasgow prognostic score can be a predictor of mortality in acute exacerbation of chronic obstructive pulmonary disease	6
Cognitive function and life quality of patients with moderate-to-severe obstructive sleep apnea-hypopnea syndrome in China	6
Calcilytics: a non-steroidal replacement for inhaled steroid and SABA/LABA therapy of human asthma?	6
Management of progressive pulmonary fibrosis associated with connective tissue disease	6
Effects of different corticosteroid therapy on severe COVID-19 patients: a meta-analysis of randomized controlled trials	6
Factors and mechanisms contributing to the development of preschool wheezing disorders	6

Diagnostic value of fractional exhaled nitric oxide in differentiating the asthma-COPD overlap from COPD: a systematic review and meta-analysis	6
The extended utility of antifibrotic therapy in progressive fibrosing interstitial lung disease	6
New perspectives on the role of muscarinic antagonists in asthma therapy	6
A multidisciplinary approach to the management of nontuberculous mycobacterial lung disease: a clinical perspective	6
The impacts of parity on spirometric parameters: a systematic review	5
The predictive value of neutrophil-to-lymphocyte ratio for chronic obstructive pulmonary disease: a systematic review and meta-analysis	5
Long-term noninvasive ventilation in COPD: current evidence and future directions	5
Obstructive sleep apnea and cardiovascular events in elderly patients	5
Indacaterol/glycopyrronium/mometasone fixed dose combination for uncontrolled asthma	5
Understanding the pathophysiology of typical acute respiratory distress syndrome and severe COVID-19	5
Impulse oscillometry: pulmonary function assessment in preschool children	5
Effects of select dietary supplements on the prevention and treatment of viral respiratory tract infections: a systematic review of randomized controlled trials	5
LncRNA HOXC-AS3 increases non-small cell lung cancer cell migration and invasion by sponging premature miR-96	5
Multi-walled carbon nanotubes induce airway hyperresponsiveness in human bronchi by stimulating sensory C-fibers and increasing the release of neuronal acetylcholine	5
Immunoactive preparations and regulatory responses in the respiratory tract: potential for clinical application in chronic inflammatory airway diseases	5
Leveraging “big data” in respiratory medicine – data science, causal inference, and precision medicine	5
Impact of renal function on the prognosis of acute pulmonary embolism patients: a systematic review and meta-analysis	5
Lung involvement associated with anti-NXP2 autoantibodies in inflammatory myopathies: a French monocenter series	5
Looking ahead to novel therapies for chronic cough. Part 1 – peripheral sensory nerve targeted treatments	5
Clinico-pathological features in fatal COVID-19 infection: a preliminary experience of a tertiary care center in North India using postmortem minimally invasive tissue sampling	5
Childhood asthma as a risk factor for adult chronic obstructive pulmonary disease: a systematic review and meta-analysis	5
Predictors of invasive mechanical ventilation in hospitalized COVID-19 patients: a retrospective study from Jordan	5
Connection between PD-L1 expression and standardized uptake value in NSCLC: an early prognostic treatment combination	5
Masks in COVID-19: let’s unmask the evidence	5
Not all nebulizers are created equal: Considerations in choosing a nebulizer for aerosol delivery during mechanical ventilation	5
An expert overview of pulmonary fibrosis in sarcoidosis	5
Current evidence on the effect of highly effective CFTR modulation on interleukin-8 in cystic fibrosis	5
Prevalence, distribution and clinical significance of joints, muscles and bones in sarcoidosis: an 18F-FDG-PET/CT study	5
Therapeutic and anti-inflammatory effects of baricitinib on mortality, ICU transfer, clinical improvement, and CRS-related laboratory parameters of hospitalized patients with moderate to severe COVID-	4
Urine biomarkers of pulmonary tuberculosis	4
Contemporary management and treatment strategies for asthma during pregnancy	4
Amikacin liposome inhalation suspension as a treatment for patients with refractory mycobacterium avium complex lung infection	4
Developments in smoking cessation interventions for patients with chronic obstructive pulmonary disease in the past 5 years: a scoping review	4
Risk factors associated with mortality in hypersensitivity pneumonitis: a meta-analysis	4
Safety and efficacy of glucocorticoids in the treatment of COVID-19: A meta-analysis of randomized control trials	4
Socioeconomic determinants of respiratory health in patients with cystic fibrosis: implications for treatment strategies	4
What is the value of electromagnetic navigation in lung cancer and to what extent does it require improvement?	4
The emerging role of mycophenolate mofetil in interstitial lung diseases	4
The triad: respiratory microbiome – virus – immune response in the pathophysiology of pulmonary viral infections	4
Prediction value of procalcitonin combining CURB-65 for 90-day mortality in community-acquired pneumonia	4
Pyoderma gangrenosum with pulmonary involvement: a pulmonary special report and literature review	4
Vascular endothelial damage in COPD: current functional assessment methods and future perspectives	4
Quantifying heterogeneity of physical and mental health-related quality of life in chronic obstructive pulmonary disease patients in the United States	4
Clinical progression and changes of chest CT findings among asymptomatic and pre-symptomatic patients with SARS-CoV-2 infection in Wuhan, China	4
How to apply the personalized medicine in obesity-associated asthma?	4
The prevalence of oropharyngeal dysphagia in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis	4
Plasmacytoid dendritic cells and asthma: a review of current knowledge	4
Insight into diagnosis of pleural tuberculosis with special focus on nucleic acid amplification tests	4
Management of COPD patients during COVID: difficulties and experiences	4
Antiviral treatment selection for SARS-CoV-2 pneumonia	4
Selexipag for the treatment of pulmonary arterial hypertension	4
Non-tuberculous mycobacteria: a disease beyond TB and preparedness in India	4
Impact of patients’ attitudes and dynamics in needs and life experiences during their journey in COPD: an ethnographic study	4
High-flow tracheal oxygen: what is the current evidence?	4
Therapeutic effect of statins on airway remodeling during asthma	4
Biopsy and re-biopsy for PD-L1 expression in NSCLC. association between PD-L1 and checkpoint inhibitor efficacy through treatment in NSCLC. A pilot study	3
Our current understanding of and approach to the management of lung cancer with pulmonary hypertension	3
Asthma and COVID-19: lessons learned and questions that remain	3
Reply to Han et al.: impact on mortality of triple ICS/LABA/LAMA therapy in a population of COPD patients including also subjects with asthma-like profile	3
Clinical recommendations for cardiopulmonary exercise testing in children with respiratory diseases	3
Robotic bronchoscopy: potential in diagnosing and treating lung cancer	3
Vaccination and modern management of chronic obstructive pulmonary disease – a narrative review	3
Radiological honeycombing: pitfalls in idiopathic pulmonary fibrosis diagnosis	3
A scoping review of longitudinal airway microbiota studies	3
C-reactive protein point of care testing: the answer to antibiotic prescribing in ambulatory patients with exacerbations of chronic obstructive pulmonary disease?	3
Noninvasive electrical stimulation of oropharyngeal muscles in obstructive sleep apnea	3
Indications and clinical outcomes of fully covered self-expandable metallic tracheobronchial stents in patients with malignant airway diseases	3
Inhaled interferons beta and SARS-COV2 infection: a preliminary therapeutic perspective	3
Aclidinium bromide/formoterol fumarate as a treatment for COPD: an update	3
Changes of peripheral lymphocyte subset in patients with SARS-CoV-2 infection during the whole course of disease	3
Mortality of intubated patients with COVID-19 during first and subsequent waves: a meta-analysis involving 363,660 patients from 43 countries	3
Analysis of prediction and early warning indexes of patients with COVID-19	3
Fixed dexmedetomidine infusion versus fixed-dose midazolam bolus as primary sedative for maintaining intra-procedural sedation during endobronchial ultrasound-guided transbronchial needle aspiration:	3
Severe acute asthma at the pediatric intensive care unit: can we link the clinical phenotypes to immunological endotypes?	3
Respiratory disturbances in fibromyalgia: A systematic review and meta-analysis of case control studies	3
Management of adult asthma and chronic rhinitis as one airway disease	3
Bronchoscopy during the COVID-19 pandemic: effect on current practices and strategies to reduce procedure-associated transmission	3
Extracorporeal membrane oxygenation in critically ill neonatal and pediatric patients with acute respiratory failure: a guide for the clinician	3
Risk factors of chronic cough in China: a systematic review and meta-analysis	3
Complications and safety analysis of diagnostic bronchoscopy in COPD: a systematic review and meta-analysis	3
Change in mortality rates of respiratory disease during the COVID-19 pandemic	3
The potential of volatile organic compound analysis for pathogen detection and disease monitoring in patients with cystic fibrosis	3
Multidisciplinary approaches to the management of malignant pleural effusions: a guide for the clinician	3
Medium-dose ICS-containing FDCs reduce all-cause mortality in COPD patients: an in-depth analysis of dual and triple therapies	3
New options for pneumothorax management	3
Impact of aging on immune function in the pathogenesis of pulmonary diseases: potential for therapeutic targets	3
Effects of high-flow nasal oxygen cannula versus other noninvasive ventilation in extubated patients: a systematic review and meta-analysis of randomized controlled trials	3
Airway disease in hematologic malignancies	3